Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology

OBJECTIVES: To investigate the comparability of WHO standard referenced commercial SARS-CoV-2 antibody tests over three doses of BNT162b2 vaccine and up to 14 months. METHODS: 114 subjects (without previous SARS-CoV-2 infection or immunosuppressive medication) vaccinated with three doses of BNT162b2...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkmann, Thomas, Mucher, Patrick, Ösze, Darlene, Müller, Antonia, Perkmann-Nagele, Nicole, Koller, Thomas, Radakovics, Astrid, Flieder, Ines, Repl, Manuela, Marculescu, Rodrig, Wolzt, Michael, Wagner, Oswald F., Binder, Christoph J., Haslacher, Helmuth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694346/
https://www.ncbi.nlm.nih.gov/pubmed/36462465
http://dx.doi.org/10.1016/j.jcv.2022.105345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694346/
https://www.ncbi.nlm.nih.gov/pubmed/36462465
http://dx.doi.org/10.1016/j.jcv.2022.105345

Ejemplares similares